Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

675

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

tablets 200 mg, 400 mg/day

DRUG

Efavirenz

tablets 600 mg, 600 mg/day

DRUG

Indinavir/ritonavir

"Indinavir: capsules 400 mg, 1600 mg/day~Ritonavir: capsules 100 mg, 200 mg/day"

DRUG

Nelfinavir

tablets 250 mg, 2500 mg/day

DRUG

Saquinavir/ritonavir

"Saquinavir: tablets 500 mg, 2000 mg/day~Ritonavir: tablets 100 mg, 200 mg/day"

DRUG

Lopinavir/ritonavir

tablets lopinavir 200 mg + ritonavir 50 mg, 800/200 mg/day

DRUG

Atazanavir

capsules 200 mg, 400 mg/day

DRUG

Atazanavir/ritonavir

"Atazanavir: capsules 150 mg, 300 mg/day~Ritonavir: capsules 100 mg, 200 mg/day"

DRUG

Fos-amprenavir/ritonavir

"Fos-amprenavir: capsules 700 mg, 1400 mg/day~Ritonavir: capsules 100 mg, 200 mg/day"

DRUG

Tipranavir/ ritonavir

"Tipranavir: tablets 250 mg, 1000 mg/day~Ritonavir: capsules 100 mg, 400 mg/day"

DRUG

Darunavir/ritonavir

"Darunavir: tablets 300 mg, 1200 mg/day~Ritonavir: capsules 100 mg, 200 mg/day"

Trial Locations (6)

17600

Hospital de Figueres, Figueras

43201

Hospital Universitari Sant Joan de Reus, Reus

08916

Germans Trias i Pujol Hospital, Badalona

08400

Fundació Hospital-Asil de Granollers, Granollers

08500

Hospital de Vic, Vic

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
collaborator

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

lead

Germans Trias i Pujol Hospital

OTHER

NCT00307502 - Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV | Biotech Hunter | Biotech Hunter